- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06003582
Co-production and Feasibility RCT of Intervention to Improve the Mental Health of Children With a Social Worker
Partnership for Change - Co-production and Feasibility Randomised Controlled Trial of an Intervention to Improve the Mental Health of Children With a Social Worker
Study Overview
Status
Intervention / Treatment
Detailed Description
Questions addressed: Can the investigators coproduce, with parent collaborators, a new service, Infant Parent Support (IPS), to improve the mental health of children with a social worker? Can the investigators test the feasibility of an RCT of IPS compared with services as usual?
Considered for entry: Parents of children aged 0-5 who have mental health concerns, social workers, and a multi-agency support plan.
Inclusion criteria: Any family in the Glasgow or Bromley trial sites with a child aged 0-5 years with mental health concerns, a social worker, and a multi-agency support plan.
Exclusion criteria: At the outset of the Trial there were no exclusion criteria.
Over the course of Phase 1, the following exclusion criteria have emerged:
- If the child has a Child Protection Plan or is on the Child Protection Register
- If the family are in the process of 'stepping down' from a CPP or CPR
- If the child is currently engaged in therapeutic work.
Intervention: Infant Parent Support (a multidisciplinary infant mental health team aiming to improve the mental health of children aged 0-5 with a social worker).
Primary Outcomes Phase 1: Coproduction, with parents of children who have a social worker, of the IPS intervention.
Phase 2: Recruitment and retention (at 3 and 6 months) to a feasibility RCT.
Secondary Outcomes
Phase 1: preliminary mapping of service context.
Phase 2:
- Improvement in the organisation, access, and quality of services, for children with a social worker and mental health issues.
- Examination of putative primary and secondary outcomes for a future definitive RCT of IPS (see below)
- Development of a parent-supported outcome measure and a parent-supported experience measure for use in a future definitive RCT
- Exploration of whether it is possible to expand into new sites to conduct a successful Phase III trial.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom
- London Borough of Bromley
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Any family in the Glasgow or Bromley trial sites with a child aged 0-5 years with mental health concerns, a social worker, and a multi-agency support plan.
Exclusion Criteria:
At the outset of the Trial there were no exclusion criteria. Over the course of Phase 1, the following exclusion criteria have emerged:
- If the child has a Child Protection Plan or is on the Child Protection Register
- If the family are in the process of 'stepping down' from a CPP or CPR
- If the child is currently engaged in therapeutic work.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Infant Parent Support
Families engage with the new therapeutic intervention, Infant Parent Support.
|
Therapeutic Intervention
|
|
No Intervention: Services As Usual
Families randomised to Services As Usual, engage with already existing services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment rates to a feasibility RCT
Time Frame: 6 months
|
The recruitment of 30 families to the Trial and the 15 families randomised to the new therapeutic intervention will be measured by recruitment rates.
|
6 months
|
|
Retention rates to a feasibility RCT
Time Frame: 1 year
|
The proportion of the 15 families randomised to the new intervention who continue through the Trial will be measured by retention rates.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helen Minnis, PhD, University of Glasgow
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 316250
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parent-Child Relations
-
University of LiegeActive, not recruitingParent-Child Relations | Child DevelopmentBelgium
-
McGill UniversitySave the Children; European Network of Foundations Children and Violence Evaluation... and other collaboratorsUnknown
-
University of CalgaryRecruitingParent-Child RelationsCanada
-
University of OttawaRecruitingParent-Child RelationsCanada
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Penn State UniversityActive, not recruiting
-
VISN 17 Center of ExcellenceUnited States Department of Defense; University of Texas at AustinEnrolling by invitation
-
University of AarhusCompletedParent-Child RelationsDenmark
-
Penn State UniversityCompleted
-
University of Wisconsin, MadisonLoyola University Chicago; Iowa State UniversityCompletedParent-Child Relations
Clinical Trials on Infant Parent Support
-
University of East LondonCompletedInfant Mental HealthUnited Kingdom
-
University of RochesterNational Institute of Mental Health (NIMH)CompletedChild Abuse
-
University Hospital, CaenWyeth is now a wholly owned subsidiary of Pfizer; Ministry of Health, FranceCompletedPreterm Birth | Parenting | Mental Health Wellness 1 | Child Development | Parent-Child Relation
-
RTI InternationalUniversity of North Carolina, Chapel HillEnrolling by invitationTuberous Sclerosis | Down Syndrome | Duchenne Muscular Dystrophy | Prader-Willi Syndrome | Fragile X Syndrome | Rett Syndrome | Turner Syndrome | Williams Syndrome | Angelman Syndrome | Chromosome 22q11.2 Deletion Syndrome | Klinefelter Syndrome | Phelan-McDermid Syndrome | Dup15Q Syndrome | Smith Magenis SyndromeUnited States
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI)CompletedAnemia, Sickle Cell | Hemoglobin SC DiseaseUnited States
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); University of AlbertaCompletedParent-Child Relations | Autism Spectrum Disorder | Parenting | Mental Health Wellness 1 | Parent-child Problem | Child Development Disorder | Child Developmental DelayCanada
-
Palo Alto UniversityAmerican Psychological FoundationCompletedKnowledge, Attitudes, Practice | Gender Identity | PrejudiceUnited States
-
Karolinska InstitutetDalarna UniversityCompleted
-
University of VirginiaChildren's National Research Institute; Medstar Health Research InstituteCompleted
-
Florida International UniversityBuffalo Prenatal Perinatal NetworkCompletedParenting | Child MaltreatmentUnited States